European Molecular Biology Laboratory Sustainability Profile
The European Molecular Biology Laboratory (EMBL) is a premier research institution headquartered in Germany, with major operational regions across France, Italy, Spain, and the United Kingdom. Founded in 1974, EMBL has established itself as a leader in molecular biology, focusing on areas such as genomics, proteomics, and bioinformatics. EMBL offers a range of core services, including advanced training, cutting-edge research facilities, and collaborative projects that drive innovation in life sciences. Its unique approach combines interdisciplinary research with state-of-the-art technology, positioning EMBL at the forefront of scientific discovery. With numerous accolades and a strong reputation in the global scientific community, EMBL continues to contribute significantly to advancements in molecular biology, fostering collaboration and excellence in research across Europe and beyond.
DitchCarbon Score
How does European Molecular Biology Laboratory's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
European Molecular Biology Laboratory's score of 36 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
European Molecular Biology Laboratory's reported carbon emissions
In 2023, the European Molecular Biology Laboratory (EMBL) reported total carbon emissions of approximately 51,713,000 kg CO2e. This figure includes 2,478,000 kg CO2e from Scope 1 emissions, 8,852,000 kg CO2e from Scope 2 emissions, and a significant 40,383,000 kg CO2e from Scope 3 emissions. The combined Scope 1 and 2 emissions totalled about 11,349,000 kg CO2e. Comparatively, in 2022, EMBL's total emissions were about 56,776,000 kg CO2e, with Scope 1 emissions at 2,986,000 kg CO2e, Scope 2 at 9,838,000 kg CO2e, and Scope 3 at 43,952,000 kg CO2e. This indicates a reduction in total emissions of approximately 5,063,000 kg CO2e from 2022 to 2023. EMBL has not disclosed any specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The organisation's commitment to sustainability is evident, but further details on formal reduction strategies are not available. Overall, EMBL's emissions data reflects a significant reliance on Scope 3 emissions, which typically encompass indirect emissions from the value chain, highlighting the importance of addressing these areas in future climate strategies.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 2,986,000 | 0,000,000 |
| Scope 2 | 9,838,000 | 0,000,000 |
| Scope 3 | 43,952,000 | 00,000,000 |
How Carbon Intensive is European Molecular Biology Laboratory's Industry?
How Carbon Intensive is European Molecular Biology Laboratory's Location?
European Molecular Biology Laboratory's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
European Molecular Biology Laboratory has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Boehringer Ingelheim Pharmaceuticals, Inc.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.